You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 21, 2024

Details for Patent: 9,272,046


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 9,272,046 protect, and when does it expire?

Patent 9,272,046 protects TOLSURA and is included in one NDA.

This patent has eighteen patent family members in ten countries.

Summary for Patent: 9,272,046
Title:Itraconazole compositions and dosage forms, and methods of using the same
Abstract: The disclosure relates to, among other things, pharmaceutical compositions, such as solid oral dosage forms, comprising itraconazole, methods of making the compositions, and methods of using the same for treating disorders including, but not limited to, fungal infections.
Inventor(s): Mudge; Stuart James (Northcote, AU), Hayes; David (Rostrevor, AU), Lukas; Stefan (Manningham, AU)
Assignee: MAYNE PHARMA INTERNATIONAL PTY. LTD. (Salisbury South, AU)
Application Number:14/511,420
Patent Claim Types:
see list of patent claims
Composition; Compound; Dosage form;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction

Patents are a crucial component of intellectual property protection, providing inventors with exclusive rights to their inventions. The U.S. Patent and Trademark Office (USPTO) is the agency responsible for granting these patents. This article will delve into the specifics of patent scope, claims, and the broader patent landscape, using the example of U.S. Patent 9,272,046 to illustrate key concepts.

What is a Patent?

A patent is a grant of exclusive rights to an inventor for a new and useful process, machine, manufacture, or composition of matter, or any improvement thereof. Patents can be categorized into several types, including utility patents, design patents, and plant patents[1].

Types of Patents

  • Utility Patents: These protect the functional aspects of an invention, such as how something works.
  • Design Patents: These protect the visual and ornamental characteristics of an invention.
  • Plant Patents: These protect new and distinct plant varieties.

The Patenting Process

The journey to obtaining a patent involves several steps:

  • Provisional Patent Application: This is an initial filing that allows the inventor to file a non-provisional patent application within one year. It provides temporary protection and is often used to assess the commercial viability of an invention[4].
  • Non-Provisional Patent Application: This is the formal application that begins the examination process by the USPTO.
  • Patent Prosecution: The process where a patent examiner reviews the application for patentability, which can take several years and may involve arguments and amendments to the claims[4].

Patent Scope and Claims

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by a patent. It is determined by the claims section of the patent, which outlines what the inventor considers to be the novel and nonobvious aspects of the invention[5].

Metrics for Measuring Patent Scope

Two key metrics for measuring patent scope are:

  • Independent Claim Length: The length of the independent claims, which are the main claims that define the invention.
  • Independent Claim Count: The number of independent claims in the patent. These metrics help in assessing the breadth and clarity of the patent claims[5].

Changes During Examination

The examination process often narrows the scope of patent claims. Patents with narrower claims at publication tend to have a higher probability of grant and a shorter examination process compared to those with broader claims[5].

Example: U.S. Patent 9,272,046

To illustrate these concepts, let's consider U.S. Patent 9,272,046, though the specific details of this patent are not provided here. Here’s how the general principles apply:

Claim Structure

  • Independent Claims: These are the primary claims that define the invention. For example, Claim 1 might describe the overall system or method.
  • Dependent Claims: These are claims that build upon the independent claims, often adding specific details or limitations.

Scope of Protection

The scope of protection for U.S. Patent 9,272,046 would be determined by the language of its claims. If the claims are narrowly defined, the patent would have a more limited scope of protection. Conversely, broader claims could potentially cover a wider range of variations, but might face more scrutiny during the examination process.

Examination Process

During the examination process, the patent examiner would review the claims to ensure they meet the criteria of novelty, nonobviousness, and enablement. Any issues or objections raised by the examiner would need to be addressed through amendments or arguments.

Patent Landscape in the United States

Trends in Patenting

The USPTO awards a significant number of patents annually. In 2018, for instance, the USPTO granted 309,000 utility patents, with a nearly equal split between foreign and domestic inventors. The majority of these patents were awarded to businesses, with individuals, academic institutions, and government entities receiving smaller shares[1].

Technology Areas

Patents are classified into various technology areas, such as electrical engineering, mechanical engineering, and chemistry. The number of electrical engineering patents, for example, more than doubled between 2000 and 2018, reflecting the growing importance of information and communication technologies (ICT)[1].

International Patent Applications

For inventions with global commercial potential, an international patent application (PCT application) can be filed. This preserves the right to file a patent in 153 countries within 30 months of the earliest priority date. However, due to the high costs involved, PCT applications are typically filed only for inventions with significant commercial value[4].

Costs and Commercial Considerations

The cost of obtaining a patent can be substantial, ranging from $8,000 to $20,000 for a U.S. non-provisional patent application, and significantly more for international patents. These costs are often borne by commercial partners if the invention has clear commercial potential[4].

Key Takeaways

  • Patent Scope: Defined by the claims section, it determines the breadth and depth of protection.
  • Claim Metrics: Independent claim length and count are crucial for measuring patent scope.
  • Examination Process: Narrows the scope of claims to ensure novelty, nonobviousness, and enablement.
  • Patent Landscape: Trends show a significant number of patents awarded annually, with a focus on technology areas like electrical engineering.
  • International Applications: PCT applications are used for global protection but come with high costs.
  • Commercial Considerations: Costs are often covered by commercial partners if the invention has commercial value.

FAQs

What is the difference between a provisional and non-provisional patent application?

A provisional patent application provides temporary protection and allows the inventor to file a non-provisional patent application within one year. A non-provisional patent application is the formal application that begins the examination process.

How is patent scope measured?

Patent scope is measured using metrics such as independent claim length and independent claim count. These metrics help in assessing the breadth and clarity of the patent claims.

What happens during the patent examination process?

During the examination process, a patent examiner reviews the application for patentability, ensuring the invention meets criteria of novelty, nonobviousness, and enablement. This process can involve amendments and arguments to the claims.

Why are PCT applications expensive?

PCT applications are expensive because they involve filing fees and the potential for national phase entry in multiple countries, which can significantly increase costs.

Can an invention be patented if it has been publicly disclosed?

In the U.S., there is a one-year grace period for filing a patent application after public disclosure. However, in most foreign countries, public disclosure before filing a patent application can result in the loss of patent protection.

Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. U.S. Patent and Trademark Office (USPTO) - USA.gov.
  3. Patent Claims Research Dataset - USPTO.
  4. Intellectual Property Protection - KU Center for Technology Commercialization.
  5. Patent Claims and Patent Scope - SSRN.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 9,272,046

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Mayne Pharma TOLSURA itraconazole CAPSULE;ORAL 208901-001 Dec 11, 2018 RX Yes Yes 9,272,046 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 9,272,046

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Australia2012902624Jun 21, 2012

International Family Members for US Patent 9,272,046

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2013278001 ⤷  Subscribe
Australia 2018201298 ⤷  Subscribe
Australia 2020217438 ⤷  Subscribe
Brazil 112014031706 ⤷  Subscribe
Canada 2876909 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.